(Press-News.org) A decade-long international study into kidney cancer has shown that doctors can predict the likelihood of a patient’s disease returning by looking at DNA mutations in their tumours.
The research, undertaken by a team of 44 researchers at 23 institutions across Europe and Canada, and published today, is the largest to link the genetic changes that occur in kidney cancer to patient outcomes.
More than 400,000 people are diagnosed with kidney cancer each year globally, including 13,000 people in the UK.
The findings may be used to develop more personalised treatment approaches for kidney cancer in the future.
Co-lead investigator Dr Naveen Vasudev, Associate Professor and Honorary Consultant in Medical Oncology in the Leeds Institute of Medical Research at St James’s, said: “Development of new treatment for kidney cancer has lagged behind other cancers and we largely continue to adopt a ‘one size fits all’ approach.
“Accurately determining the risk of recurrence is very important. As well as helping us identify how often patients need to be seen by their doctors, it helps us to decide who to treat with immunotherapy. This treatment has recently been shown to reduce the chances of the cancer coming back but can cause side-effects. The danger currently is that some patients may be over-treated, so being able to better identify patients at low risk of recurrence is important since they could be spared more treatment.”
Published today by the University of Leeds and McGill University in Montreal, the study looked at changes in the DNA of more than 900 kidney cancer samples and identified four groups of patients based on the mutations in 12 specific genes within the DNA. The team also looked at whether the cancer had recurred in each of these patients.
The researchers found some 91% of patients in one mutation group remained disease-free five years after surgery, meaning patients in this group may potentially avoid unnecessary treatment. Meanwhile, the percentage of patients in a different mutation group who remained disease-free at five years was much lower, at 51%. This identified them as requiring more aggressive treatment.
Preventing cancer recurrence
Currently, doctors assess the risk of kidney cancer returning by looking at features like the size of the tumour and how aggressive it appears under a microscope. With up to 30% of localized kidney cancers returning after surgery, more accurate methods of assessing this risk are needed, meaning patients who do not need further treatment can be spared it.
The new study shows that genes can be used to better predict the likelihood of recurrence. This method, called DNA sequencing, is already available through the NHS for other cancers. These results mean that tumour DNA sequencing may provide a more effective way to predict a patient’s risk of kidney cancer recurrence.
Dr Vasudev said: “Genomics - the study of genes and how they interact with each other – is a key area of development in patient care for the NHS. Here we show how genomics might be applied to patients with kidney cancer, potentially creating more personalised treatment options for thousands of patients each year.”
Co-lead investigator Dr Yasser Riazalhosseini, Assistant Professor of Human Genetics, and Head of Cancer Genomics at Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University, said: “Our research shows that it may be possible to improve the way we determine risk in each patient by looking at the genetic mutations present in their cancer. DNA sequencing is already being used to help patients with other types of cancer and so could be readily applied to patients with kidney cancer.”
Further information
“Application of genomic sequencing to refine patient stratification for adjuvant therapy in renal cell carcinoma” is published today in Clinical Cancer Research.
The results are part of a wider research project into kidney cancer by the Cancer Genomics of the Kidney (CAGEKID) consortium, an extensive collaborative network of 14 partners from six EU countries and Russia. CAGEKID was initiated in 2010 by Professor Mark Lathrop, Scientific Director of Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University, as part of the International Cancer Genome Consortium (ICGC).
Contact University of Leeds press officer Lauren Ballinger via l.ballinger@leeds.ac.uk with media enquiries.
University of Leeds
The University of Leeds is one of the largest higher education institutions in the UK, with more than 38,000 students from more than 150 different countries. We are renowned globally for the quality of our teaching and research.
We are a values-driven university, and we harness our expertise in research and education to help shape a better future for humanity, working through collaboration to tackle inequalities, achieve societal impact and drive change.
The University is a member of the Russell Group of research-intensive universities, and plays a significant role in the Turing, Rosalind Franklin and Royce Institutes. www.leeds.ac.uk
Follow University of Leeds or tag us into coverage: Twitter | Facebook | LinkedIn | Instagram
END
Genes reveal kidney cancer’s risk of recurrence
2023-02-23
ELSE PRESS RELEASES FROM THIS DATE:
Getting good sleep could add years to your life
2023-02-23
Getting good sleep can play a role in supporting your heart and overall health—and maybe even how long you live—according to new research being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology. The study found that young people who have more beneficial sleep habits are incrementally less likely to die early. Moreover, the data suggest that about 8% of deaths from any cause could be attributed to poor sleep patterns.
“We saw ...
Hormone therapy for gender dysphoria may raise cardiovascular risks
2023-02-23
People with gender dysphoria taking hormone replacements as part of gender affirmation therapy face a substantially increased risk of serious cardiac events, including stroke, heart attack and pulmonary embolism, according to a study presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
Gender dysphoria occurs when a person’s gender identity conflicts with the sex they were assigned at birth. Gender affirmation therapy, part of a process known as transitioning, includes a variety of medical, psychological and behavioral interventions to help ...
Heart attack deaths drop over past two decades
2023-02-23
The U.S. not only saw a significant decline in the overall rate of heart attack-related deaths in the past 20 years, but also a reduction in racial disparities for heart attack deaths, according to a study presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology. The gap in the rate of heart attack deaths between White people and African American/Black people narrowed by nearly half over the 22-year period, researchers reported.
The ...
Clinical trials often overlook people with disabilities
2023-02-23
Disabilities were underreported in clinical trial data and commonly used as a basis for exclusion from trial participation in an analysis of 80 recent trials involving cardiovascular outcomes, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
Reports estimate that over half of people with heart disease have one or more disabilities related to cognition, mobility, vision, independent living, self-care or hearing as defined by the Centers for Disease Control and Prevention (CDC). However, the new study found that 38% of clinical ...
Individuals with long COVID more likely to experience heart problems
2023-02-23
Experiencing lasting symptoms months after catching COVID-19, also known as long COVID, was found to more than double a person’s likelihood of developing cardiovascular issues, according to a study being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
The study—a systematic literature review and meta-analysis of 11 major studies involving a total of 5.8 million people—represents the most comprehensive effort to date to examine cardiovascular complications from long COVID. Estimates of the number of people affected by long COVID vary substantially, but recent surveys suggest about 1 in 7 ...
Lifelong bachelors face poorest prognosis with heart failure
2023-02-23
Men who never married were more than twice as likely to die within about five years after a heart failure diagnosis compared with women of any marital status or men who were previously married, according to a study presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
The study offers new evidence that a person’s gender and marital status can influence their heart disease risk and prognosis. Heart failure, when the heart muscle becomes too weak ...
Your Facebook friendships may influence your heart health
2023-02-23
Places with higher rates of economic connectedness—linkages between people of lower and higher socioeconomic status as indicated by Facebook friendships—had significantly lower rates of premature death related to heart disease, according to a study presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
Previous studies have shown that poverty or low socioeconomic status increases a person’s risk of heart disease and premature death. This new study is ...
Too little sodium can be harmful to heart failure patients
2023-02-23
For people with heart failure, restricting dietary sodium intake to levels below the standard recommended maximum of about 2.3 grams per day does not bring additional benefits and may increase the risk of death, according to findings from nine randomized controlled trials in a new meta-analysis presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology.
Heart failure, in which the heart muscle becomes too weak or stiff to pump blood effectively, is a chronic condition affecting over 6 million adults in the U.S. Physicians recommend a low-sodium diet to reduce blood pressure and avoid common symptoms ...
Researchers identify biomarker for diagnosing vascular dementia
2023-02-23
Measuring a key blood molecule may help doctors diagnose whether or how much impaired blood flow to a patient’s brain is contributing to dementia or cognitive problems, according to a new study led by a UCLA Health researcher.
Cerebral small vessel disease, a common disease marked by damage to the cells lining the blood vessels in the brain, is a major driver of cognitive problems and dementia in older adults. However, it can be difficult for doctors to determine whether a patient’s cognitive impairments stem predominately from Alzheimer’s disease or vascular problems, the two most common causes of ...
Pairing students supports integration at universities
2023-02-23
The university world is international, but grapples with difficulties in integrating students from different countries. New research from Chalmers University of Technology, Sweden, points to a method that both reduces academic and social gaps and increases well-being. The recipe for success is to work in pairs – as chosen by the teacher.
There is plenty of research indicating that integration is a decisive factor for a successful student life, both socially and academically, for the individual and for the university. Students who are involved in activities and feel connected to their fellow students can get higher grades and are more likely to continue ...